STOCK TITAN

Eton Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Eton Pharmaceuticals (Nasdaq: ETON) announced that CEO Sean Brynjelsen will present at the H.C. Wainwright 24th Annual Global Investment Conference on September 14, 2022, at 1:30 PM ET. The presentation will be available via webcast on the company's investor relations website. Eton focuses on developing treatments for rare diseases and currently markets products like ALKINDI SPRINKLE® and Carglumic Acid tablets. The company has additional rare disease products in development and is entitled to milestone payments or royalties on several products.

Positive
  • None.
Negative
  • None.

DEER PARK, Ill., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that Sean Brynjelsen, Chief Executive Officer, will present at the H.C. Wainwright 24th Annual Global Investment Conference as follows:    

Date:Wednesday, September 14, 2022
Time:1:30PM ET
Webcast: Click Here

The webcast will be accessible via the Company’s website at https://ir.etonpharma.com/ the Investors section under Events and Presentations.

Eton will be participating in 1x1 meetings, which can be requested via H.C. Wainwright.

About Eton Pharmaceuticals
Eton Pharmaceuticals, Inc. is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. The Company currently commercializes ALKINDI SPRINKLE® and Carglumic Acid tablets and has two additional rare disease products under development, dehydrated alcohol injection and the ZENEO® hydrocortisone autoinjector. In addition, the Company is entitled to receive milestone payments or royalties on seven different products.

Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com

Source: Eton Pharmaceuticals, Inc.


FAQ

When will Eton Pharmaceuticals present at the H.C. Wainwright conference?

Eton Pharmaceuticals will present on September 14, 2022.

What time is the Eton Pharmaceuticals presentation scheduled for?

The presentation is scheduled for 1:30 PM ET.

Where can I watch the Eton Pharmaceuticals presentation?

The presentation will be available via a webcast on Eton's investor relations website.

What products does Eton Pharmaceuticals currently commercialize?

Eton Pharmaceuticals currently markets ALKINDI SPRINKLE® and Carglumic Acid tablets.

What is the focus of Eton Pharmaceuticals?

Eton Pharmaceuticals focuses on developing and commercializing treatments for rare diseases.

Eton Pharmaceutcials, Inc.

NASDAQ:ETON

ETON Rankings

ETON Latest News

ETON Stock Data

329.55M
25.24M
5.39%
33.36%
0.74%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
DEER PARK